RAPID MICRO BIOSYSTEMS INC-A (RPID) Stock Price & Overview

NASDAQ:RPID • US75340L1044

Current stock price

2.3399 USD
-0.16 (-6.4%)
Last:

The current stock price of RPID is 2.3399 USD. Today RPID is down by -6.4%. In the past month the price decreased by -37.03%. In the past year, price decreased by -3.47%.

RPID Key Statistics

52-Week Range1.86 - 4.94
Current RPID stock price positioned within its 52-week range.
1-Month Range2.41 - 4.58
Current RPID stock price positioned within its 1-month range.
Market Cap
106.372M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.07
Dividend Yield
N/A

RPID Stock Performance

Today
-6.4%
1 Week
-27.01%
1 Month
-37.03%
3 Months
-20.63%
Longer-term
6 Months -25.82%
1 Year -3.47%
2 Years +157.73%
3 Years +90.84%
5 Years N/A
10 Years N/A

RPID Stock Chart

RAPID MICRO BIOSYSTEMS INC-A / RPID Daily stock chart

RPID Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to RPID. When comparing the yearly performance of all stocks, RPID is a bad performer in the overall market: 77.66% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

RPID Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to RPID. The financial health of RPID is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RPID Earnings

On March 12, 2026 RPID reported an EPS of -0.28 and a revenue of 11.28M. The company missed EPS expectations (-23.38% surprise) and missed revenue expectations (-2.55% surprise).

Next Earnings DateMay 7, 2026
Last Earnings DateMar 12, 2026
PeriodQ4 / 2025
EPS Reported-$0.28
Revenue Reported11.282M
EPS Surprise -23.38%
Revenue Surprise -2.55%

RPID Forecast & Estimates

10 analysts have analysed RPID and the average price target is 8.16 USD. This implies a price increase of 248.73% is expected in the next year compared to the current price of 2.3399.

For the next year, analysts expect an EPS growth of 17.78% and a revenue growth 18.95% for RPID


Analysts
Analysts84
Price Target8.16 (248.73%)
EPS Next Y17.78%
Revenue Next Year18.95%

RPID Groups

Sector & Classification

RPID Financial Highlights

Over the last trailing twelve months RPID reported a non-GAAP Earnings per Share(EPS) of -1.07. The EPS increased by 0.93% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-44.29M
Industry RankSector Rank
PM (TTM) N/A
ROA -52.47%
ROE -99.91%
Debt/Equity 0.43
Chartmill High Growth Momentum
EPS Q2Q%-27.27%
Sales Q2Q%37.28%
EPS 1Y (TTM)0.93%
Revenue 1Y (TTM)N/A

RPID Ownership

Ownership
Inst Owners57.91%
Shares45.46M
Float36.29M
Ins Owners4.63%
Short Float %0.62%
Short Ratio0.79

About RPID

Company Profile

RPID logo image Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 171 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Company Info

IPO: 2021-07-15

RAPID MICRO BIOSYSTEMS INC-A

25 Hartwell Avenue

Lexington MASSACHUSETTS US

CEO: Robert Spignesi

Employees: 171

RPID Company Website

RPID Investor Relations

Phone: 19783493200

RAPID MICRO BIOSYSTEMS INC-A / RPID FAQ

Can you describe the business of RAPID MICRO BIOSYSTEMS INC-A?

Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 171 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.


Can you provide the latest stock price for RAPID MICRO BIOSYSTEMS INC-A?

The current stock price of RPID is 2.3399 USD. The price decreased by -6.4% in the last trading session.


What is the dividend status of RAPID MICRO BIOSYSTEMS INC-A?

RPID does not pay a dividend.


What is the ChartMill technical and fundamental rating of RPID stock?

RPID has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the analyst forecast for RPID stock?

10 analysts have analysed RPID and the average price target is 8.16 USD. This implies a price increase of 248.73% is expected in the next year compared to the current price of 2.3399.


Is RAPID MICRO BIOSYSTEMS INC-A (RPID) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RPID.


Can you provide the ownership details for RPID stock?

You can find the ownership structure of RAPID MICRO BIOSYSTEMS INC-A (RPID) on the Ownership tab.